ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,914Medicare Part D Prescriptions Filled, Including Refills

Rank: 148 out of 625

$587K Total Retail Price of All Prescriptions

Rank: 142 out of 625

997 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 997 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 997 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 8,481 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
SIMVASTATIN 617 595 1 2
LISINOPRIL 414 398 2 5
LEVOTHYROXINE SODIUM 366 341 3 3
AMLODIPINE BESYLATE 308 292 4 1
OMEPRAZOLE 280 276 5 6
ZOLPIDEM TARTRATE 261 252 6 13
PRAVASTATIN SODIUM 252 229 7 8
LOSARTAN POTASSIUM 238 219 8 18
ATORVASTATIN CALCIUM 202 193 9 9
METFORMIN HCL 181 173 10 10
FLUTICASONE PROPIONATE 171 162 11 32
METOPROLOL TARTRATE 165 163 12 11
TRIAMTERENE-HCTZ 146 142 13 53
AZITHROMYCIN 138 132 14 40
HYDROCHLOROTHIAZIDE 137 122 15 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 130 126 16 27
CRESTOR 122 121 17 17
CARVEDILOL 114 111 18 23
LOSARTAN-HYDROCHLOROTHIAZIDE 107 104 19 38
FUROSEMIDE 106 103 20 7
WARFARIN SODIUM 103 101 21 20
PAROXETINE HCL 97 97 22 76
METOPROLOL SUCCINATE 96 96 23 15
ATENOLOL 96 94 23 22
ALENDRONATE SODIUM 93 93 25 34
TERAZOSIN HCL 91 85 26 149
TRAMADOL HCL 87 86 27 16
CITALOPRAM HBR 79 73 28 24
NEXIUM 79 72 28 21
HYDROCODONE-ACETAMINOPHEN 76 71 S3 30 4
ALLOPURINOL 70 67 31 29
NAPROXEN 67 64 32 104
SYNTHROID 63 63 33 39
TAMSULOSIN HCL 62 62 34 36
PREDNISONE 61 61 35 37
ADVAIR DISKUS 58 58 36 63
CIPROFLOXACIN HCL 58 55 36 60
LIPITOR 57 55 38 75
DIOVAN HCT 56 56 39 52
METHYLPREDNISOLONE 55 54 40 120
SERTRALINE HCL 54 54 41 26
DIOVAN 52 51 42 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.